CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.370
+0.080 (2.43%)
Aug 25, 2026, 4:00 PM EDT - Market closed
CytomX Therapeutics Employees
CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or -42.98% compared to the previous year.
Employees
69
Change (1Y)
-52
Growth (1Y)
-42.98%
Revenue / Employee
$265,261
Profits / Employee
-$1,197,899
Market Cap
734.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | -52 | -42.98% | 69 | 0 |
| Dec 31, 2024 | 121 | -1 | -0.82% | 119 | 2 |
| Dec 31, 2023 | 122 | 4 | 3.39% | 120 | 2 |
| Dec 31, 2022 | 118 | -60 | -33.71% | 116 | 2 |
| Dec 31, 2021 | 178 | 32 | 21.92% | 174 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsCTMX News
- 9 days ago - CytomX Therapeutics price target lowered to $11 from $12 at JPMorgan - TheFly
- 15 days ago - CytomX Therapeutics price target lowered to $14 from $15 at Guggenheim - TheFly
- 19 days ago - CytomX Therapeutics reports Q2 EPS (9c), consensus (10c) - TheFly
- 19 days ago - CytomX Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 19 days ago - CytomX Therapeutics Quarterly report: Q2 2026 - Filings
- 19 days ago - CytomX Therapeutics Earnings release: Q2 2026 - Filings
- 19 days ago - CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 22 days ago - CytomX Therapeutics appoints Alejandra Carvajal as chief legal officer - TheFly